Associated adverse outcomes with tumor treating fields when combined to temozolomide versus temozolomide alone for the treatment of glioblastoma: a meta-analysis of randomized trials
Abstract Background Glioma is a brain tumor and glioblastoma represents its most common type, accounting for almost 40% of primary tumors of the central nervous system, and is associated with the worst prognosis. Glioblastoma remains one of the major challenges in neurooncology. Recently, the Food a...
Saved in:
Main Authors: | Yuanyuan Chen, Yan Chen, Hong Zhen, Danhua Lou |
---|---|
Format: | Article |
Language: | English |
Published: |
SpringerOpen
2025-02-01
|
Series: | Egyptian Journal of Neurosurgery |
Subjects: | |
Online Access: | https://doi.org/10.1186/s41984-025-00342-8 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Factors involved in maintaining Karnofsky Performance Status (≥ 50%) in glioblastoma, IDH-wildtype patients treated with temozolomide and radiotherapy
by: Shigeo Ohba, et al.
Published: (2025-01-01) -
Magnetic and pH sensitive nanocomposite microspheres for controlled temozolomide delivery in glioblastoma cells
by: Meysam Ahmadi, et al.
Published: (2024-12-01) -
Prolonged Remission in Metastatic Ano‐Rectal Malignant Melanoma With Single Agent Temozolomide
by: Anusha Mruthyunjaya Swamy, et al.
Published: (2025-01-01) -
Synergism of d-limonene and temozolomide on migratory and apoptotic behaviors of human glioblastoma cell lines
by: Megha Gautam, et al.
Published: (2024-09-01) -
Development and Validation of a Prognostic Molecular Phenotype and Clinical Characterization in Grade III Diffuse Gliomas Treatment with Radio-Chemotherapy
by: Gu W, et al.
Published: (2025-01-01)